Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target Lowered to $33.00 at Cantor Fitzgerald

Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target Lowered to $33.00 at Cantor Fitzgerald

Cantor Fitzgerald cut their target price on Ultragenyx Pharmaceutical from $103.00 to $33.00 and set an "overweight" rating for the company in a research note on Thursday.

Ultragenyx Pharmaceutical (NASDAQ:RARE) Downgraded by Wells Fargo & Company to “Equal Weight”

Ultragenyx Pharmaceutical (NASDAQ:RARE – Get Free Report) was downgraded by analysts at Wells Fargo & Company from an “overweight” rating to an “equal weight” rating in a report released on Thursday, Briefing.com reports. They currently have a $18.00 price objective on the biopharmaceutical company’s stock. Wells Fargo & Company‘s target price suggests a potential downside […]